Donald W. Fallon
Director of Finance/CFO at AXION INTERNATIONAL HOLDINGS INC.
Profile
Donald W.
Fallon is a member of The American Institute of Certified Public Accountants and the Chief Financial Officer & Treasurer at Axion International Holdings, Inc. He previously worked as the Director-Finance & Accounting at Guilford Pharmaceuticals, Inc. from 2000 to 2002, as the Chief Financial Officer at Osiris Therapeutics, Inc. from 2002 to 2003, and as the Chief Financial Officer & Secretary at Ceptor Corp.
(Maryland).
He also worked as the Chief Financial Officer at Morphochem, Inc. from 1998 to 2000.
Mr. Fallon holds an MBA from Loyola University Maryland, Inc. and an undergraduate degree from the University of Baltimore.
Donald W. Fallon active positions
Companies | Position | Start |
---|---|---|
AXION INTERNATIONAL HOLDINGS INC. | Director of Finance/CFO | 2010-11-14 |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Corporate Officer/Principal | - |
Former positions of Donald W. Fallon
Companies | Position | End |
---|---|---|
OSIRIS THERAPEUTICS, INC. | Director of Finance/CFO | 2003-11-30 |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Director of Finance/CFO | 2002-04-30 |
Morphochem, Inc.
Morphochem, Inc. Pharmaceuticals: MajorHealth Technology Morphochem, Inc. manufactures and develops drugs. It uses proprietary whole-cell high throughput screening systems to discover novel compounds of therapeutic value for disorders including cancer & immunological, infectious & metabolic diseases, and for applications in agriculture. The company was founded by Prabhavathi Fernandes in 1997 and is located in Monmouth Junction, NJ | Director of Finance/CFO | 1999-12-31 |
Ceptor Corp. (Maryland)
Ceptor Corp. (Maryland) Pharmaceuticals: MajorHealth Technology CepTor Corp. develops and provides therapeutic products for neuro mascular and neuro degenerative diseases. The firm's technology includes the development of products for multiple sclerosis, chronic inflammatory demyelinating polyneuropathy, and amyotrophic lateral sclerosis diseases. The company was founded in 1986 and is headquartered in Hunt Valley, MD. | Director of Finance/CFO | - |
Training of Donald W. Fallon
Loyola University Maryland, Inc. | Masters Business Admin |
University of Baltimore | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 6 |
---|---|
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
Osiris Therapeutics, Inc.
Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
Ceptor Corp. (Maryland)
Ceptor Corp. (Maryland) Pharmaceuticals: MajorHealth Technology CepTor Corp. develops and provides therapeutic products for neuro mascular and neuro degenerative diseases. The firm's technology includes the development of products for multiple sclerosis, chronic inflammatory demyelinating polyneuropathy, and amyotrophic lateral sclerosis diseases. The company was founded in 1986 and is headquartered in Hunt Valley, MD. | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Commercial Services |
Morphochem, Inc.
Morphochem, Inc. Pharmaceuticals: MajorHealth Technology Morphochem, Inc. manufactures and develops drugs. It uses proprietary whole-cell high throughput screening systems to discover novel compounds of therapeutic value for disorders including cancer & immunological, infectious & metabolic diseases, and for applications in agriculture. The company was founded by Prabhavathi Fernandes in 1997 and is located in Monmouth Junction, NJ | Health Technology |
Axion International Holdings, Inc.
Axion International Holdings, Inc. Industrial SpecialtiesProcess Industries Axion International Holdings, Inc. manufactures markets and sells composite rail ties and structural building products. It delivers tested, proven and superior green solutions to plastics manufacturers and infrastructure needs around the globe through its business segments. The firm offers ECOTRAX rail products, such as main line, road crossing, tunnel-ties and tunnel-tie systems, pre-plated ties, and switch ties. The company was founded by James Joseph Kerstein in 1981 and is headquartered in Zanesville, OH. | Process Industries |
- Stock Market
- Insiders
- Donald W. Fallon